US-China ink gene therapy research agreement for Duchenne Muscular Dystrophy
Therapeutics | News | 0 Comment | 02 Nov, 2021
CANbridge Pharmaceuticals, Inc., a leading China-based global rare disease-focused biopharmaceutical company has entered...Read more
Australia uses ‘Live’ brain models to hunt for Alzheimer’s treatment
Therapeutics | News | 0 Comment | 02 Nov, 2021
Studying tiny ‘live’ models of the human brain has helped researchers understand its ageing and find a key t...Read more
Australia develops bionic technology to assist people with nerve damage
Therapeutics | News | 0 Comment | 29 Oct, 2021
A shoe insole using bionic technology to help people with nerve damage maintain their balance has been designed by Unive...Read more
Clinical trial for generalised anxiety disorder receives ethics approval in Australia
Therapeutics | News | 0 Comment | 28 Oct, 2021
Monash University in Australia has obtained ethics approval for a world-first clinical trial investigating psilocybin-as...Read more
Singapore creates device that uses ‘light tweezers’ to trap viruses
Therapeutics | News | 0 Comment | 27 Oct, 2021
A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) has created a laser-powered devi...Read more
Japan proposes drug cocktail to stop SARS-CoV-2 infection of stem cells
Therapeutics | News | 0 Comment | 27 Oct, 2021
A team of scientists at the Center for iPS Cell Research and Application (CiRA), Kyoto University in Japan, has sho...Read more
Korea builds technique to measure blood flow in brain in 'Real Time'
Therapeutics | News | 0 Comment | 22 Oct, 2021
Cerebral blood flow (CBF), which supplies oxygen and nutrients to our brain, is a crucial indicator of brain health. Inf...Read more
Australia invests $85M to find solutions for major questions in human health
Therapeutics | News | 0 Comment | 22 Oct, 2021
Seventeen multidisciplinary research teams will each receive $5 million in funding from the Australian government to fin...Read more
Australia boosts stem cell research with grants worth $25M
Therapeutics | News | 0 Comment | 21 Oct, 2021
The government is boosting Australian led stem cell research through $25 million in grants, to help find and develop inn...Read more
Korean startup D&D Pharmatech secures $51M ahead of IPO in 2022
Therapeutics | News | 0 Comment | 20 Oct, 2021
D&D Pharmatech Inc., a South Korea-based clinical-stage biotechnology startup focused on development and commerciali...Read more
Combating ageing with pharmacological interventions
Therapeutics | Opinion | By Dr Yu-Xuan Lu, Ageing Scientist, Max Planck Institute for Biology of Ageing, Germany | 2 Comment | 19 Oct, 2021
The increasing ageing population represents a remarked worldwide socioeconomic challenge. Pharmacological interven...Read more
Singapore performs first-in-man trial for vision repair using regenerative therapy
Therapeutics | News | 0 Comment | 19 Oct, 2021
With the advent of induced pluripotent stem cell (iPSC) and embryonic stem cell (ESC) technology, regenerative stem cell...Read more
World's first long-acting herpes treatment trial taking place in US, China
Therapeutics | News | 93 Comment | 19 Oct, 2021
Shanghai Public Health Clinical Centre and Cheng Kung University's Department of Microbiology and Immunology have joined...Read more
Australia explores 'cell fitness' for predicting health outcomes in COVID-19 patients
Therapeutics | News | 0 Comment | 19 Oct, 2021
Cell fitness has been identified as a way of predicting health outcomes in COVID-19 patients, according to a University ...Read more
TB research in NZ to make ‘enormous global health impact’
Therapeutics | News | 0 Comment | 18 Oct, 2021
New Zealand's University of Otago researchers are behind a major scientific breakthrough which could lead to elimination...Read more
Japan identifies molecules for building stronger antibodies
Therapeutics | News | 0 Comment | 15 Oct, 2021
A team of researchers at the Institute for the Advanced Study of Human Biology (ASHBi) at Kyoto University, Japan&n...Read more
Singapore to revolutionise therapeutics for cancer & infectious diseases
Therapeutics | News | 0 Comment | 14 Oct, 2021
Scientists from Duke-NUS Medical School have partnered with Singapore biotechnology company Xylonix ...Read more
Australia's Topelia to raises $25M in Series A funding for Antiviral Triple Therapy (ATT)
Therapeutics | News | 0 Comment | 14 Oct, 2021
Topelia Australia, a biotech company established to commercialize a novel ATT treatment for Australians in quarantine, h...Read more